– UK, Winsford – Advanced Medical Solutions Group plc (LON: AMS), the world-leading specialist in tissue-healing technologies, announced the appointment of Susan Searle to its Board as an additional Independent Non-Executive Director with immediate effect.
Grahame Cook, Chair of AMS, said: “I am very pleased to welcome Susan to the Board of AMS. She has a wealth of Board experience with growth companies, including healthcare companies. She will be an extremely valuable addition to our Board.”
About Susan Searle
Susan Searle has extensive experience on public and private company boards in several sectors, including healthcare. She is currently a Non-Executive Director of Gooch & Housego plc, where she is Chair of the Remuneration and Sustainability Committees, as well as being a Non-Executive of Bibby Line Group Limited and Chair of Greenback Recycling Technologies Limited. She has recently stepped down from QinetiQ plc, where she was a Non-Executive Director and Remuneration Committee Chair, having served three full terms.
Susan Searle was formerly Non-Executive Senior Independent Director and Remuneration Chair of Horizon Discovery plc and Benchmark Holdings Plc, both technology businesses. She also chaired two listed investment businesses – Mercia Asset Management plc and Schroders UK Public Private Trust plc, and was a founder of Touchstone Innovations plc, where she served as its CEO. She holds an MA in Chemistry from Oxford University.
Susan Searle said: “I have followed AMS progress over the last few years and am excited to be joining the Board as the company continues its growth journey.”
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec, and Seal-G. AMS also supplies wound care dressings such as silver alginates, alginates, and foams through its ActivHeal brand as well as under a white label. Since 2019, the Group has made seven acquisitions: Sealantis, an Israeli developer of innovative internal sealants; Biomatlante, a French developer and manufacturer of surgical biomaterials; Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials; AFS Medical, an Austrian specialist surgical business; Connexicon, an Irish tissue adhesives specialist; Syntacoll, a German specialist in collagen-based absorbable surgical implants; and Peters Surgical, a global provider of specialty surgical sutures, mechanical hemostasis, and internal cyanoacrylate devices.
AMS’s products, manufactured in the UK, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, Austria, France, Poland, Benelux, India, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France, and Israel. Established in 1991, the Group has more than 1,500 employees.
For more: https://www.admedsol.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.